Evidence map›Paper›PMID 28966445›Full record

ArticleProceedings (Baylor University. Medical Center)2017

Urinary metabolites in patients undergoing coronary catheterization via the radial versus femoral artery approach.

Anupama Vasudevan, Jeffrey M Schussler, Jane I Won, Paula Ashcraft, Ivy Bolanos, Matthew Williams, Teodoro Bottiglieri, Carlos E Velasco, Peter A McCullough

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Anupama VasudevanBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Jeffrey M SchusslerBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Jane I WonBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Paula AshcraftBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Ivy BolanosBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Matthew WilliamsBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Teodoro BottiglieriBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Carlos E VelascoBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Peter A McCulloughBaylor Heart and Vascular Institute, Dallas, Texas (Vasudevan, Schussler, Won, Velasco, McCullough); Texas A&M Health Science Center College of Medicine, Dallas Campus, Dallas Texas (Vasudevan, Schussler, McCullough); Baylor Scott & White Research Institute, Dallas, Texas (Vasudevan, Won); Baylor University Medical Center, Dallas, Texas (Schussler, Velasco, McCullough); and Baylor Scott & White Research Institute of Metabolic Disease, Dallas, Texas (Ashcraft, Bolanos, Williams, Bottiglieri).
Baylor Jack and Jane Hamilton Heart and Vascular Hospital · USTexas A&M Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transradial approach (TRA) for coronary angiography and percutaneous coronary intervention is associated with lower rates of vascular complications and acute kidney injury when compared to the transfemoral approach (TFA). Urine metabolites and proteins may be useful in identifying the dynamic changes at the vascular endothelial cell level. We attempted to explore the changes in the measurable signals of endothelial and nephron injury within 60 to 90 minutes after catheterization among those with the TRA and TFA approaches. Consecutive patients of a single interventionist who underwent coronary angiography between June 2015 and May 2016 were included. Of the 60 patients included in the analysis, the baseline characteristics were similar between those with a TRA (n = 30) and TFA (n = 30) approach. The values of the biomarkers were natural log transformed for the analysis. We found that the mean values of heat shock protein 27, taurine, and sulfuric acid did not significantly change after the procedure. However, the median value of thioredoxin decreased (

Identifiers

PMID28966445
PMCPMC5595375
OpenAlexW2793576314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.